chr1-29260618-A-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_133178.4(PTPRU):ā€‹c.859A>Gā€‹(p.Thr287Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000133 in 1,500,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000073 ( 0 hom., cov: 32)
Exomes š‘“: 0.00014 ( 0 hom. )

Consequence

PTPRU
NM_133178.4 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.87
Variant links:
Genes affected
PTPRU (HGNC:9683): (protein tyrosine phosphatase receptor type U) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem intracellular catalytic domains, and thus represents a receptor-type PTP. The extracellular region contains a meprin-A5 antigen-PTP (MAM) domain, Ig-like and fibronectin type III-like repeats. This PTP was thought to play roles in cell-cell recognition and adhesion. Studies of the similar gene in mice suggested the role of this PTP in early neural development. The expression of this gene was reported to be regulated by phorbol myristate acetate (PMA) or calcium ionophore in Jurkat T lymphoma cells. Alternatively spliced transcript variants have been reported. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17097783).
BS2
High AC in GnomAd4 at 11 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PTPRUNM_133178.4 linkuse as main transcriptc.859A>G p.Thr287Ala missense_variant 7/30 ENST00000373779.8
PTPRUNM_005704.5 linkuse as main transcriptc.859A>G p.Thr287Ala missense_variant 7/31
PTPRUNM_133177.4 linkuse as main transcriptc.859A>G p.Thr287Ala missense_variant 7/31
PTPRUNM_001195001.2 linkuse as main transcriptc.859A>G p.Thr287Ala missense_variant 7/30

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PTPRUENST00000373779.8 linkuse as main transcriptc.859A>G p.Thr287Ala missense_variant 7/301 NM_133178.4 A1Q92729-2

Frequencies

GnomAD3 genomes
AF:
0.0000726
AC:
11
AN:
151530
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000243
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000657
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000133
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000136
AC:
22
AN:
162200
Hom.:
0
AF XY:
0.000151
AC XY:
13
AN XY:
86362
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000282
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000140
AC:
189
AN:
1348634
Hom.:
0
Cov.:
31
AF XY:
0.000153
AC XY:
101
AN XY:
660128
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000340
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000176
Gnomad4 OTH exome
AF:
0.0000360
GnomAD4 genome
AF:
0.0000726
AC:
11
AN:
151530
Hom.:
0
Cov.:
32
AF XY:
0.0000811
AC XY:
6
AN XY:
73964
show subpopulations
Gnomad4 AFR
AF:
0.0000243
Gnomad4 AMR
AF:
0.0000657
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000133
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000110
Hom.:
0
Bravo
AF:
0.0000907
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000117
AC:
14

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 27, 2022The c.859A>G (p.T287A) alteration is located in exon 7 (coding exon 7) of the PTPRU gene. This alteration results from a A to G substitution at nucleotide position 859, causing the threonine (T) at amino acid position 287 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.42
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.10
T;.;.;.
Eigen
Benign
-0.0053
Eigen_PC
Benign
0.041
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.90
D;D;D;D
M_CAP
Benign
0.033
D
MetaRNN
Benign
0.17
T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.5
L;L;L;L
MutationTaster
Benign
1.0
D;D;D;D;D;D
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-1.7
N;N;N;N
REVEL
Benign
0.044
Sift
Benign
0.10
T;T;T;T
Sift4G
Benign
0.068
T;T;T;T
Polyphen
0.60
P;P;P;P
Vest4
0.35
MVP
0.51
MPC
1.4
ClinPred
0.12
T
GERP RS
3.9
Varity_R
0.11
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148349447; hg19: chr1-29587130; API